|
Matrix executes definitive Agreement to acquire the residual holding of Mr.Mark Gao, the erstwhile promoter of Mchem Group of Companies
Matrix records net sales of Rs.4470 million and net profit of Rs.269 million for Q1 FY08
Matrix records net sales of Rs. 16,480 million and net profit of RS.763 million for FY07
Matrix records net sales
of Rs. 3,953 million in Q3FY07
Mylan Laboratories Completes
Matrix Laboratories Transaction
Matrix records net sales
of Rs.4422 million and
net profit of Rs.338 million
for Q1FY07
Matrix records net sales
of Rs.11586 million and
net profit of Rs.1992 million
for FY-06
Clarification given to
Times of India/Stock Exchanges
Matrix posts consolidated net profit of Rs. 100 Cr for Q3
Matrix to acquire controlling stake in Concord Biotech
Matrix plans preferential issue of 35 lakh equity shares at Rs.225 per share to the erstwhile promoters of Docpharma
Matrix posts, on consolidated
basis, record sales of Rs.
291.58 crore and net profit of
Rs. 43.69 crore for Q2
Matrix Laboratories completes
the acquisition of Docpharma
by obtaining 95.51% stake in
the public takeover bid
Matrix enters Definitive
Agreement for acquiring
controlling stake in Mchem
Group, China
Mylan Laboratories to Acquire
Up to 71.5% Controlling
Interest in Matrix Laboratories
|
